Nicholson Nur (CIK 0001827317)

Latest company ownership

APLS - Apellis Pharmaceuticals, Inc.
Role: Chief Technical Officer
Shares held
83,664
Last filed at
Jan 30, 2025
Confidence Score
50.3
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 29, 2025 Jan 30, 2025 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 48.8 -825 -0.98% ✗ $24.4K
Jan 22, 2025 Jan 23, 2025 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 42.5 -3,948 -4.46% ✗ $120.1K
Jan 17, 2025 Jan 21, 2025 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 95.0 +34,281 63.30% ✗ $64.3K
Jan 13, 2025 Jan 14, 2025 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 42.5 -2,632 -4.63% ✗ $75.5K
Mar 13, 2024 Mar 14, 2024 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 20.0 -11,220 -16.62% ✗ $645.8K
Jan 29, 2024 Jan 31, 2024 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 42.5 -835 -1.22% ✗ $53.6K
Jan 22, 2024 Jan 23, 2024 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 42.5 -2,593 -3.66% ✗ $168.5K
Jan 16, 2024 Jan 17, 2024 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 95.0 +17,651 33.13% ✗ $124.1K
Sep 18, 2023 Sep 19, 2023 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 20.0 -20,350 -27.64% ✗ $900.8K
Feb 21, 2023 Feb 22, 2023 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 91.3 +9,061 16.64% ✗ $48.3K
Jan 27, 2023 Jan 30, 2023 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 26.3 -551 -1.00% ✗ $29.1K
Jan 20, 2023 Jan 24, 2023 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 22.5 -2,034 -3.57% ✗ $105.9K
Jan 28, 2022 Feb 1, 2022 Apellis Pharmaceuticals, Inc. Chief Technical Officer Sell 46.3 -650 -1.80% ✗ $25.1K